Reflections on the Evolution of Ovarian Cancer Guidelines

Robert L. Coleman, MD


June 15, 2021

Dr Robert Coleman, chief scientific officer of the US Oncology Network, reflects on the evolution of ovarian cancer treatment guidelines from early in his career to the dramatic shifts in the past few years. Coleman also discusses current gaps in the guidelines and the need for more global participation in clinical trials.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.